Connect with us


Vision Health Company Raises $6.4M to Develop Dry-Eye Product

It’s conducting a study in Sjögren’s syndrome dry eye patients.




TearSolutions Inc., a Charlottesville, VA-based biopharmaceutical company, announced the completion of a $6.4 million financing round.

The company will use the funds to complete a pivotal FDA Phase II clinical trial for LacripepTM, its lead product candidate.

The clinical trial is being conducted with 201 primary Sjögren’s syndrome dry eye patients at 27 investigational sites across the U.S. A new site is opening soon at the University of Virginia.

LacripepTM is a naturally occurring peptide found in normal tears that has been shown to be deficient in all forms of dry eye tears.

Primary Sjögren’s syndrome patient’s tears are particularly deficient in LacripepTM, according to a press release from the company. Administration of LacripepTM in a Sjögren’s animal model has shown “a dramatic restoration of normal tearing and corneal health.”


“The dry eye market in the US is just over $2 billion, and neither of the two FDA approved products address the root cause,” said Dr. Tom Gadek, president and CEO of the company.

“As a natural replacement therapy, LacripepTM could meet a huge unmet need.”

Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at [email protected].


Sponsored by Shamir

Customer Focused, Service Oriented, Forward Thinking

Shamir is the recognized world leader in custom-designed technology for life improvement, fashion, performance sports, occupational single vision, and progressive lenses. Our values, the driving force behind our ideas and actions, keep the ECP in the center. Every Shamir representative is personally committed to our customers’ vision, and to providing the best service and support to meet and exceed their expectations, all with a personal touch.

Click here for more information.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular